PT  - JOURNAL ARTICLE
AU  - Essa, Hani
AU  - Jackson, Carolyn
AU  - Nyjo, Siji
AU  - Kelly, Ann-Marie
AU  - Murphy, Naomi
AU  - Hartshorne-Evans, Nick
AU  - Walker, Lauren
AU  - Oguguo, Emeka
AU  - Douglas, Homeyra
AU  - Sankaranarayanan, Rajiv
TI  - Use of a Self-Care and Educational Mobile App to Improve Outcomes of Patients with Acute Decompensated Heart Failure during the COVID-19 Pandemic
AID  - 10.1101/2022.07.28.22270513
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.28.22270513
4099  - http://medrxiv.org/content/early/2022/08/01/2022.07.28.22270513.short
4100  - http://medrxiv.org/content/early/2022/08/01/2022.07.28.22270513.full
AB  - Introduction Expansion in digital health using mobile phone health applications has increased recently. We developed a mobile phone application (Aintree Heart Failure Passport-AHFP APP) for heart failure (HF) patient education, self-care and improved medication adherence.Methods This was a prospective observational study of patients with acute decompensated HF managed with day-case intravenous diuretics in a HF specialist nurse delivered Ambulatory Acute Heart Failure Unit (AAHFU) in a British university hospital during the ongoing COVID-19 pandemic (March 2020 to July 2021). We assessed self-care behaviour (European Heart Failure Self-care Behaviour scale – EHFSBs-9) and medication adherence (Medication Adherence Report Scale -MARS-5) at 2 weeks post-presentation in patients who utilised the AHFP APP and compared 30-day HF re-admissions with annual hospital HF data.Results 148 out of 221 consecutive ADHF patients treated in the AAHFU downloaded the AHFP Mobile APP. 45% were women and mean age of the cohort 62 ± 6.1 years. 55% patients had HF with reduced ejection fraction (HFrEF), 34% had HF with preserved EF (HFpEF) and 11% had HF with mildly reduced EF. Mean EHFSBs-9 was 19.1±6.7; mean MARS-5 score 23.3±1.HF 30 day re-hospitalisation incidence significantly lower (11%) in the APP cohort compared to the incidence of 19% amongst all patients with ADHF during the study period (p=0.02).Conclusions Our pilot feasibility study suggests that use of a HF educational self-care mobile phone APP in ADHF patients during the COVID pandemic, leads to high quality self-care behaviour, high medication adherence and also lower levels of 30-day HF re-hospitalisation. These results will need to be validated in a randomised controlled trial.3 Key PointsThe use of digital healthcare technologies such as mobile APPs, is rapidly increasingThis study analyses the role of our heart failure educational and self-care mobile APP, used by patients with acute decompensated heart failure during the COVID-19 pandemicOur results show that use of the mobile APP can lead to high levels of self-care, medication adherence and also reduced 30 day readmissionsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementDr Sankaranarayanan developed the The Aintree Heart Failure Passport Mobile APP through an 8000 pound grant from the Director's Drganon's Den from Aintree University Hospital (Liverpool University Hospitals NHS Foundation Trust)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Research and Audit Governance Committee of Liverpool University Hospitals NHS Foundation Trust gave ethical approval for this work as service evaluationI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors